NOTCH AND PLK1: TARGETING NOVEL MECHANISMS IN B-ALL

被引：0
|
作者：
Zweidler-McKay, Patrick [1 ]
Kannan, Sankaranarayanan [1 ]
Fang, Wendy [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
PEDIATRIC BLOOD & CANCER | 2011年 / 56卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：922 / 922
页数：1
相关论文
共 50 条
  • [1] TARGETING NOTCH AND PLK1 IN HUMAN B-ALL: A NOVEL TUMOR SUPPRESSING MECHANISM AND A THERAPEUTIC TARGET.
    Kannan, Sankar
    Golfman, Leonard
    Hall, Mandy
    Zweidler-McKay, Patrick
    PEDIATRIC BLOOD & CANCER, 2014, 61 : S1 - S2
  • [2] Notch Signaling In B-ALL Reveals PLK1 As A Potential Therapeutic Target In B-ALL: PLK1-Selective Inhibitor Poloxin Modulates Cyclin B and P53 Pathways, Leading To Growth Arrest and Apoptosis
    Kannan, Sankaranarayanan
    Hall, Mandy A.
    Golfman, Leonard S.
    Zweidler-McKay, Patrick A.
    BLOOD, 2013, 122 (21)
  • [3] Multiple Mechanisms of Notch-Mediated B-ALL Growth Arrest Via HES1 and PLK1: KIF11, CyclinB and p53
    Kannan, Sankaranarayanan
    Fang, Wendy
    Zweidler-McKay, Patrick
    BLOOD, 2010, 116 (21) : 1292 - 1293
  • [4] A novel type II inhibitor targeting Plk1
    Keppner, Sarah
    Proschak, Ewgenij
    Schneider, Gisbert
    Spaenkuch, Birgit
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2009, 24 : S17 - S17
  • [5] Targeting Plk1 for cancer therapy
    Schmidt, Mathias
    Hofmann, Hans-Peter
    Sanders, Karl
    Gekeler, Volker
    Beckers, Thomas
    EJC SUPPLEMENTS, 2006, 4 (06): : 16 - 16
  • [6] Targeting PLK1 and Aurora kinases in medulloblastoma
    Holst, M.
    Westerhout, E.
    Kool, M.
    Caron, H.
    Versteeg, R.
    Clifford, S.
    Rutkowski, S.
    Pietsch, T.
    KLINISCHE PADIATRIE, 2012, 224 (03): : 222 - 222
  • [7] Notch/HES1 Signaling Stabilizes p53 Expression Via a Novel PARP1-Chfr-PLK1-Mediated Mechanism in B-ALL
    Kannan, Sankaranarayanan
    Zweidler-McKay, Patrick A.
    BLOOD, 2012, 120 (21)
  • [8] Molecular Targeting of the Oncoprotein PLK1 in Pediatric Acute Myeloid Leukemia: RO3280, a Novel PLK1 Inhibitor, Induces Apoptosis in Leukemia Cells
    Wang, Na-Na
    Li, Zhi-Heng
    Zhao, He
    Tao, Yan-Fang
    Xu, Li-Xiao
    Lu, Jun
    Cao, Lan
    Du, Xiao-Juan
    Sun, Li-Chao
    Zhao, Wen-Li
    Xiao, Pei-Fang
    Fang, Fang
    Su, Guang-Hao
    Li, Yan-Hong
    Li, Gang
    Li, Yi-Ping
    Xu, Yun-Yun
    Zhou, Hui-Ting
    Wu, Yi
    Jin, Mei-Fang
    Liu, Lin
    Ni, Jian
    Wang, Jian
    Hu, Shao-Yan
    Zhu, Xue-Ming
    Feng, Xing
    Pan, Jian
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2015, 16 (01): : 1266 - 1292
  • [9] TARGETING OF NOTCH SIGNALING IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL) DRUG RESPONSE
    Dal Collo, G.
    Kamga, P. Takam
    Midolo, M.
    Adamo, A.
    Delfino, P.
    Mercuri, A.
    Cesaro, S.
    Mimiola, E.
    Nordlund, J.
    Bonifacio, M.
    Andreini, A.
    Chilosi, M.
    Krampera, M.
    HAEMATOLOGICA, 2018, 103 : S57 - S57
  • [10] Targeting overexpressed PLK1 and Aurora kinases in childhood medulloblastorna
    Holst, Martin I.
    Westerhout, Ellen
    Kool, Marcel
    Caron, Huib
    Versteeg, Rogier
    Clifford, Steve
    Rutkowski, Stefan
    Pietsch, Torsten
    CANCER RESEARCH, 2011, 71
12345